Decitabine Market
1 Study Coverage
1.1 Decitabine Product Introduction
1.2 Market by Type
1.2.1 Global Decitabine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 10 Mg Dosage Forms
1.2.3 15 Mg Dosage Forms
1.2.4 25 Mg Dosage Forms
1.3 Market by Application
1.3.1 Global Decitabine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Primary MDS
1.3.3 Secondary MDS
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Decitabine Sales Estimates and Forecasts 2017-2028
2.2 Global Decitabine Revenue Estimates and Forecasts 2017-2028
2.3 Global Decitabine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Decitabine Sales by Region
2.4.1 Global Decitabine Sales by Region (2017-2022)
2.4.2 Global Sales Decitabine by Region (2023-2028)
2.5 Global Decitabine Revenue by Region
2.5.1 Global Decitabine Revenue by Region (2017-2022)
2.5.2 Global Decitabine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Decitabine Sales by Manufacturers
3.1.1 Global Top Decitabine Manufacturers by Sales (2017-2022)
3.1.2 Global Decitabine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Decitabine in 2021
3.2 Global Decitabine Revenue by Manufacturers
3.2.1 Global Decitabine Revenue by Manufacturers (2017-2022)
3.2.2 Global Decitabine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Decitabine Revenue in 2021
3.3 Global Decitabine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Decitabine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Decitabine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Decitabine Sales by Type
4.1.1 Global Decitabine Historical Sales by Type (2017-2022)
4.1.2 Global Decitabine Forecasted Sales by Type (2023-2028)
4.1.3 Global Decitabine Sales Market Share by Type (2017-2028)
4.2 Global Decitabine Revenue by Type
4.2.1 Global Decitabine Historical Revenue by Type (2017-2022)
4.2.2 Global Decitabine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Decitabine Revenue Market Share by Type (2017-2028)
4.3 Global Decitabine Price by Type
4.3.1 Global Decitabine Price by Type (2017-2022)
4.3.2 Global Decitabine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Decitabine Sales by Application
5.1.1 Global Decitabine Historical Sales by Application (2017-2022)
5.1.2 Global Decitabine Forecasted Sales by Application (2023-2028)
5.1.3 Global Decitabine Sales Market Share by Application (2017-2028)
5.2 Global Decitabine Revenue by Application
5.2.1 Global Decitabine Historical Revenue by Application (2017-2022)
5.2.2 Global Decitabine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Decitabine Revenue Market Share by Application (2017-2028)
5.3 Global Decitabine Price by Application
5.3.1 Global Decitabine Price by Application (2017-2022)
5.3.2 Global Decitabine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Decitabine Market Size by Type
6.1.1 North America Decitabine Sales by Type (2017-2028)
6.1.2 North America Decitabine Revenue by Type (2017-2028)
6.2 North America Decitabine Market Size by Application
6.2.1 North America Decitabine Sales by Application (2017-2028)
6.2.2 North America Decitabine Revenue by Application (2017-2028)
6.3 North America Decitabine Market Size by Country
6.3.1 North America Decitabine Sales by Country (2017-2028)
6.3.2 North America Decitabine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Decitabine Market Size by Type
7.1.1 Europe Decitabine Sales by Type (2017-2028)
7.1.2 Europe Decitabine Revenue by Type (2017-2028)
7.2 Europe Decitabine Market Size by Application
7.2.1 Europe Decitabine Sales by Application (2017-2028)
7.2.2 Europe Decitabine Revenue by Application (2017-2028)
7.3 Europe Decitabine Market Size by Country
7.3.1 Europe Decitabine Sales by Country (2017-2028)
7.3.2 Europe Decitabine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Decitabine Market Size by Type
8.1.1 Asia Pacific Decitabine Sales by Type (2017-2028)
8.1.2 Asia Pacific Decitabine Revenue by Type (2017-2028)
8.2 Asia Pacific Decitabine Market Size by Application
8.2.1 Asia Pacific Decitabine Sales by Application (2017-2028)
8.2.2 Asia Pacific Decitabine Revenue by Application (2017-2028)
8.3 Asia Pacific Decitabine Market Size by Region
8.3.1 Asia Pacific Decitabine Sales by Region (2017-2028)
8.3.2 Asia Pacific Decitabine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Decitabine Market Size by Type
9.1.1 Latin America Decitabine Sales by Type (2017-2028)
9.1.2 Latin America Decitabine Revenue by Type (2017-2028)
9.2 Latin America Decitabine Market Size by Application
9.2.1 Latin America Decitabine Sales by Application (2017-2028)
9.2.2 Latin America Decitabine Revenue by Application (2017-2028)
9.3 Latin America Decitabine Market Size by Country
9.3.1 Latin America Decitabine Sales by Country (2017-2028)
9.3.2 Latin America Decitabine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Decitabine Market Size by Type
10.1.1 Middle East and Africa Decitabine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Decitabine Revenue by Type (2017-2028)
10.2 Middle East and Africa Decitabine Market Size by Application
10.2.1 Middle East and Africa Decitabine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Decitabine Revenue by Application (2017-2028)
10.3 Middle East and Africa Decitabine Market Size by Country
10.3.1 Middle East and Africa Decitabine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Decitabine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Overview
11.1.3 Johnson & Johnson Decitabine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Johnson & Johnson Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Johnson & Johnson Recent Developments
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Corporation Information
11.2.2 Eli Lilly and Company Overview
11.2.3 Eli Lilly and Company Decitabine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Eli Lilly and Company Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Eli Lilly and Company Recent Developments
11.3 Pharmachemie B.V.
11.3.1 Pharmachemie B.V. Corporation Information
11.3.2 Pharmachemie B.V. Overview
11.3.3 Pharmachemie B.V. Decitabine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Pharmachemie B.V. Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pharmachemie B.V. Recent Developments
11.4 Otsuka Pharmaceutical
11.4.1 Otsuka Pharmaceutical Corporation Information
11.4.2 Otsuka Pharmaceutical Overview
11.4.3 Otsuka Pharmaceutical Decitabine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Otsuka Pharmaceutical Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Otsuka Pharmaceutical Recent Developments
11.5 Sandoz
11.5.1 Sandoz Corporation Information
11.5.2 Sandoz Overview
11.5.3 Sandoz Decitabine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sandoz Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sandoz Recent Developments
11.6 Dr Reddy's Laboratories
11.6.1 Dr Reddy's Laboratories Corporation Information
11.6.2 Dr Reddy's Laboratories Overview
11.6.3 Dr Reddy's Laboratories Decitabine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Dr Reddy's Laboratories Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Dr Reddy's Laboratories Recent Developments
11.7 Accord Healthcare
11.7.1 Accord Healthcare Corporation Information
11.7.2 Accord Healthcare Overview
11.7.3 Accord Healthcare Decitabine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Accord Healthcare Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Accord Healthcare Recent Developments
11.8 Sun Pharmaceutical
11.8.1 Sun Pharmaceutical Corporation Information
11.8.2 Sun Pharmaceutical Overview
11.8.3 Sun Pharmaceutical Decitabine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sun Pharmaceutical Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sun Pharmaceutical Recent Developments
11.9 Cipla
11.9.1 Cipla Corporation Information
11.9.2 Cipla Overview
11.9.3 Cipla Decitabine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Cipla Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Cipla Recent Developments
11.10 Lupin
11.10.1 Lupin Corporation Information
11.10.2 Lupin Overview
11.10.3 Lupin Decitabine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Lupin Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Lupin Recent Developments
11.11 Shandong Xinshidai Pharmaceutical
11.11.1 Shandong Xinshidai Pharmaceutical Corporation Information
11.11.2 Shandong Xinshidai Pharmaceutical Overview
11.11.3 Shandong Xinshidai Pharmaceutical Decitabine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Shandong Xinshidai Pharmaceutical Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Shandong Xinshidai Pharmaceutical Recent Developments
11.12 Hangzhou Zhongmei Huadong Pharmaceutical
11.12.1 Hangzhou Zhongmei Huadong Pharmaceutical Corporation Information
11.12.2 Hangzhou Zhongmei Huadong Pharmaceutical Overview
11.12.3 Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Hangzhou Zhongmei Huadong Pharmaceutical Recent Developments
11.13 ZHENGDA Tianqing Pharmaceutical Group
11.13.1 ZHENGDA Tianqing Pharmaceutical Group Corporation Information
11.13.2 ZHENGDA Tianqing Pharmaceutical Group Overview
11.13.3 ZHENGDA Tianqing Pharmaceutical Group Decitabine Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 ZHENGDA Tianqing Pharmaceutical Group Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 ZHENGDA Tianqing Pharmaceutical Group Recent Developments
11.14 Jiangsu Aosaikang Pharmaceutical
11.14.1 Jiangsu Aosaikang Pharmaceutical Corporation Information
11.14.2 Jiangsu Aosaikang Pharmaceutical Overview
11.14.3 Jiangsu Aosaikang Pharmaceutical Decitabine Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Jiangsu Aosaikang Pharmaceutical Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
11.15 Jiangsu Haosen Pharmaceutical Group
11.15.1 Jiangsu Haosen Pharmaceutical Group Corporation Information
11.15.2 Jiangsu Haosen Pharmaceutical Group Overview
11.15.3 Jiangsu Haosen Pharmaceutical Group Decitabine Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Jiangsu Haosen Pharmaceutical Group Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Jiangsu Haosen Pharmaceutical Group Recent Developments
11.16 Lianyungang Jierui Pharmaceutical
11.16.1 Lianyungang Jierui Pharmaceutical Corporation Information
11.16.2 Lianyungang Jierui Pharmaceutical Overview
11.16.3 Lianyungang Jierui Pharmaceutical Decitabine Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Lianyungang Jierui Pharmaceutical Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Lianyungang Jierui Pharmaceutical Recent Developments
11.17 Qilu Pharmaceutical Hainan
11.17.1 Qilu Pharmaceutical Hainan Corporation Information
11.17.2 Qilu Pharmaceutical Hainan Overview
11.17.3 Qilu Pharmaceutical Hainan Decitabine Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Qilu Pharmaceutical Hainan Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Qilu Pharmaceutical Hainan Recent Developments
11.18 Lianyungang Runzhong Pharmaceutical
11.18.1 Lianyungang Runzhong Pharmaceutical Corporation Information
11.18.2 Lianyungang Runzhong Pharmaceutical Overview
11.18.3 Lianyungang Runzhong Pharmaceutical Decitabine Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Lianyungang Runzhong Pharmaceutical Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Lianyungang Runzhong Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Decitabine Industry Chain Analysis
12.2 Decitabine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Decitabine Production Mode & Process
12.4 Decitabine Sales and Marketing
12.4.1 Decitabine Sales Channels
12.4.2 Decitabine Distributors
12.5 Decitabine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Decitabine Industry Trends
13.2 Decitabine Market Drivers
13.3 Decitabine Market Challenges
13.4 Decitabine Market Restraints
14 Key Findings in The Global Decitabine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Decitabine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 10 Mg Dosage Forms
Table 3. Major Manufacturers of 15 Mg Dosage Forms
Table 4. Major Manufacturers of 25 Mg Dosage Forms
Table 5. Global Decitabine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Decitabine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Decitabine Sales by Region (2017-2022) & (K Units)
Table 8. Global Decitabine Sales Market Share by Region (2017-2022)
Table 9. Global Decitabine Sales by Region (2023-2028) & (K Units)
Table 10. Global Decitabine Sales Market Share by Region (2023-2028)
Table 11. Global Decitabine Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Decitabine Revenue Market Share by Region (2017-2022)
Table 13. Global Decitabine Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Decitabine Revenue Market Share by Region (2023-2028)
Table 15. Global Decitabine Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Decitabine Sales Share by Manufacturers (2017-2022)
Table 17. Global Decitabine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Decitabine Revenue Share by Manufacturers (2017-2022)
Table 19. Decitabine Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Decitabine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Decitabine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Decitabine as of 2021)
Table 22. Decitabine Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Decitabine Product Offered
Table 24. Date of Manufacturers Enter into Decitabine Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Decitabine Sales by Type (2017-2022) & (K Units)
Table 27. Global Decitabine Sales by Type (2023-2028) & (K Units)
Table 28. Global Decitabine Sales Share by Type (2017-2022)
Table 29. Global Decitabine Sales Share by Type (2023-2028)
Table 30. Global Decitabine Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Decitabine Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Decitabine Revenue Share by Type (2017-2022)
Table 33. Global Decitabine Revenue Share by Type (2023-2028)
Table 34. Decitabine Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Decitabine Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global Decitabine Sales by Application (2017-2022) & (K Units)
Table 37. Global Decitabine Sales by Application (2023-2028) & (K Units)
Table 38. Global Decitabine Sales Share by Application (2017-2022)
Table 39. Global Decitabine Sales Share by Application (2023-2028)
Table 40. Global Decitabine Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Decitabine Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Decitabine Revenue Share by Application (2017-2022)
Table 43. Global Decitabine Revenue Share by Application (2023-2028)
Table 44. Decitabine Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Decitabine Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America Decitabine Sales by Type (2017-2022) & (K Units)
Table 47. North America Decitabine Sales by Type (2023-2028) & (K Units)
Table 48. North America Decitabine Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Decitabine Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Decitabine Sales by Application (2017-2022) & (K Units)
Table 51. North America Decitabine Sales by Application (2023-2028) & (K Units)
Table 52. North America Decitabine Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Decitabine Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Decitabine Sales by Country (2017-2022) & (K Units)
Table 55. North America Decitabine Sales by Country (2023-2028) & (K Units)
Table 56. North America Decitabine Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Decitabine Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Decitabine Sales by Type (2017-2022) & (K Units)
Table 59. Europe Decitabine Sales by Type (2023-2028) & (K Units)
Table 60. Europe Decitabine Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Decitabine Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Decitabine Sales by Application (2017-2022) & (K Units)
Table 63. Europe Decitabine Sales by Application (2023-2028) & (K Units)
Table 64. Europe Decitabine Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Decitabine Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Decitabine Sales by Country (2017-2022) & (K Units)
Table 67. Europe Decitabine Sales by Country (2023-2028) & (K Units)
Table 68. Europe Decitabine Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Decitabine Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Decitabine Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Decitabine Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Decitabine Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Decitabine Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Decitabine Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Decitabine Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Decitabine Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Decitabine Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Decitabine Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Decitabine Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Decitabine Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Decitabine Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Decitabine Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Decitabine Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Decitabine Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Decitabine Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Decitabine Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Decitabine Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Decitabine Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Decitabine Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Decitabine Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Decitabine Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Decitabine Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Decitabine Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Decitabine Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Decitabine Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Decitabine Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Decitabine Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Decitabine Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Decitabine Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Decitabine Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Decitabine Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Decitabine Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Decitabine Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Decitabine Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Decitabine Revenue by Country (2023-2028) & (US$ Million)
Table 106. Johnson & Johnson Corporation Information
Table 107. Johnson & Johnson Description and Major Businesses
Table 108. Johnson & Johnson Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. Johnson & Johnson Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Johnson & Johnson Recent Developments
Table 111. Eli Lilly and Company Corporation Information
Table 112. Eli Lilly and Company Description and Major Businesses
Table 113. Eli Lilly and Company Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. Eli Lilly and Company Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Eli Lilly and Company Recent Developments
Table 116. Pharmachemie B.V. Corporation Information
Table 117. Pharmachemie B.V. Description and Major Businesses
Table 118. Pharmachemie B.V. Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. Pharmachemie B.V. Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Pharmachemie B.V. Recent Developments
Table 121. Otsuka Pharmaceutical Corporation Information
Table 122. Otsuka Pharmaceutical Description and Major Businesses
Table 123. Otsuka Pharmaceutical Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. Otsuka Pharmaceutical Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Otsuka Pharmaceutical Recent Developments
Table 126. Sandoz Corporation Information
Table 127. Sandoz Description and Major Businesses
Table 128. Sandoz Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. Sandoz Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Sandoz Recent Developments
Table 131. Dr Reddy's Laboratories Corporation Information
Table 132. Dr Reddy's Laboratories Description and Major Businesses
Table 133. Dr Reddy's Laboratories Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 134. Dr Reddy's Laboratories Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Dr Reddy's Laboratories Recent Developments
Table 136. Accord Healthcare Corporation Information
Table 137. Accord Healthcare Description and Major Businesses
Table 138. Accord Healthcare Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 139. Accord Healthcare Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Accord Healthcare Recent Developments
Table 141. Sun Pharmaceutical Corporation Information
Table 142. Sun Pharmaceutical Description and Major Businesses
Table 143. Sun Pharmaceutical Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 144. Sun Pharmaceutical Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Sun Pharmaceutical Recent Developments
Table 146. Cipla Corporation Information
Table 147. Cipla Description and Major Businesses
Table 148. Cipla Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 149. Cipla Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Cipla Recent Developments
Table 151. Lupin Corporation Information
Table 152. Lupin Description and Major Businesses
Table 153. Lupin Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 154. Lupin Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Lupin Recent Developments
Table 156. Shandong Xinshidai Pharmaceutical Corporation Information
Table 157. Shandong Xinshidai Pharmaceutical Description and Major Businesses
Table 158. Shandong Xinshidai Pharmaceutical Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 159. Shandong Xinshidai Pharmaceutical Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Shandong Xinshidai Pharmaceutical Recent Developments
Table 161. Hangzhou Zhongmei Huadong Pharmaceutical Corporation Information
Table 162. Hangzhou Zhongmei Huadong Pharmaceutical Description and Major Businesses
Table 163. Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 164. Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. Hangzhou Zhongmei Huadong Pharmaceutical Recent Developments
Table 166. ZHENGDA Tianqing Pharmaceutical Group Corporation Information
Table 167. ZHENGDA Tianqing Pharmaceutical Group Description and Major Businesses
Table 168. ZHENGDA Tianqing Pharmaceutical Group Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 169. ZHENGDA Tianqing Pharmaceutical Group Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. ZHENGDA Tianqing Pharmaceutical Group Recent Developments
Table 171. Jiangsu Aosaikang Pharmaceutical Corporation Information
Table 172. Jiangsu Aosaikang Pharmaceutical Description and Major Businesses
Table 173. Jiangsu Aosaikang Pharmaceutical Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 174. Jiangsu Aosaikang Pharmaceutical Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
Table 175. Jiangsu Aosaikang Pharmaceutical Recent Developments
Table 176. Jiangsu Haosen Pharmaceutical Group Corporation Information
Table 177. Jiangsu Haosen Pharmaceutical Group Description and Major Businesses
Table 178. Jiangsu Haosen Pharmaceutical Group Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 179. Jiangsu Haosen Pharmaceutical Group Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
Table 180. Jiangsu Haosen Pharmaceutical Group Recent Developments
Table 181. Lianyungang Jierui Pharmaceutical Corporation Information
Table 182. Lianyungang Jierui Pharmaceutical Description and Major Businesses
Table 183. Lianyungang Jierui Pharmaceutical Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 184. Lianyungang Jierui Pharmaceutical Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
Table 185. Lianyungang Jierui Pharmaceutical Recent Developments
Table 186. Qilu Pharmaceutical Hainan Corporation Information
Table 187. Qilu Pharmaceutical Hainan Description and Major Businesses
Table 188. Qilu Pharmaceutical Hainan Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 189. Qilu Pharmaceutical Hainan Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
Table 190. Qilu Pharmaceutical Hainan Recent Developments
Table 191. Lianyungang Runzhong Pharmaceutical Corporation Information
Table 192. Lianyungang Runzhong Pharmaceutical Description and Major Businesses
Table 193. Lianyungang Runzhong Pharmaceutical Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 194. Lianyungang Runzhong Pharmaceutical Decitabine Product Model Numbers, Pictures, Descriptions and Specifications
Table 195. Lianyungang Runzhong Pharmaceutical Recent Developments
Table 196. Key Raw Materials Lists
Table 197. Raw Materials Key Suppliers Lists
Table 198. Decitabine Distributors List
Table 199. Decitabine Customers List
Table 200. Decitabine Market Trends
Table 201. Decitabine Market Drivers
Table 202. Decitabine Market Challenges
Table 203. Decitabine Market Restraints
Table 204. Research Programs/Design for This Report
Table 205. Key Data Information from Secondary Sources
Table 206. Key Data Information from Primary Sources
List of Figures
Figure 1. Decitabine Product Picture
Figure 3. Global Decitabine Market Share by Type in 2021 & 2028
Figure 3. 10 Mg Dosage Forms Product Picture
Figure 4. 15 Mg Dosage Forms Product Picture
Figure 5. 25 Mg Dosage Forms Product Picture
Figure 6. Global Decitabine Market Share by Application in 2021 & 2028
Figure 7. Primary MDS
Figure 8. Secondary MDS
Figure 9. Decitabine Report Years Considered
Figure 10. Global Decitabine Sales 2017-2028 (K Units)
Figure 11. Global Decitabine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Decitabine Revenue 2017-2028 (US$ Million)
Figure 13. Global Decitabine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Decitabine Sales Market Share by Region (2017-2022)
Figure 15. Global Decitabine Sales Market Share by Region (2023-2028)
Figure 16. North America Decitabine Sales YoY (2017-2028) & (K Units)
Figure 17. North America Decitabine Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Decitabine Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Decitabine Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Decitabine Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Decitabine Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Decitabine Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Decitabine Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Decitabine Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Decitabine Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Decitabine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Decitabine in the World: Market Share by Decitabine Revenue in 2021
Figure 28. Global Decitabine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Decitabine Sales Market Share by Type (2017-2028)
Figure 30. Global Decitabine Revenue Market Share by Type (2017-2028)
Figure 31. Global Decitabine Sales Market Share by Application (2017-2028)
Figure 32. Global Decitabine Revenue Market Share by Application (2017-2028)
Figure 33. North America Decitabine Sales Market Share by Type (2017-2028)
Figure 34. North America Decitabine Revenue Market Share by Type (2017-2028)
Figure 35. North America Decitabine Sales Market Share by Application (2017-2028)
Figure 36. North America Decitabine Revenue Market Share by Application (2017-2028)
Figure 37. North America Decitabine Sales Share by Country (2017-2028)
Figure 38. North America Decitabine Revenue Share by Country (2017-2028)
Figure 39. U.S. Decitabine Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Decitabine Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Decitabine Sales Market Share by Type (2017-2028)
Figure 42. Europe Decitabine Revenue Market Share by Type (2017-2028)
Figure 43. Europe Decitabine Sales Market Share by Application (2017-2028)
Figure 44. Europe Decitabine Revenue Market Share by Application (2017-2028)
Figure 45. Europe Decitabine Sales Share by Country (2017-2028)
Figure 46. Europe Decitabine Revenue Share by Country (2017-2028)
Figure 47. Germany Decitabine Revenue (2017-2028) & (US$ Million)
Figure 48. France Decitabine Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Decitabine Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Decitabine Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Decitabine Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Decitabine Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Decitabine Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Decitabine Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Decitabine Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Decitabine Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Decitabine Revenue Share by Region (2017-2028)
Figure 58. China Decitabine Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Decitabine Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Decitabine Revenue (2017-2028) & (US$ Million)
Figure 61. India Decitabine Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Decitabine Revenue (2017-2028) & (US$ Million)
Figure 63. Taiwan Decitabine Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Decitabine Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Decitabine Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Decitabine Revenue (2017-2028) & (US$ Million)
Figure 67. Philippines Decitabine Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Decitabine Sales Market Share by Type (2017-2028)
Figure 69. Latin America Decitabine Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Decitabine Sales Market Share by Application (2017-2028)
Figure 71. Latin America Decitabine Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Decitabine Sales Share by Country (2017-2028)
Figure 73. Latin America Decitabine Revenue Share by Country (2017-2028)
Figure 74. Mexico Decitabine Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Decitabine Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Decitabine Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Decitabine Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Decitabine Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Decitabine Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Decitabine Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Decitabine Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Decitabine Revenue Share by Country (2017-2028)
Figure 83. Turkey Decitabine Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Decitabine Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Decitabine Revenue (2017-2028) & (US$ Million)
Figure 86. Decitabine Value Chain
Figure 87. Decitabine Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
Industry Market Size
